Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
For short-term financial goals, saving may be a wiser choice than investing. Understand the reasons behind this practical approach.
28,327 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A new wave of legal challenges has hit kardashian’s skims with lawsuit, shaking up the brand’s polished image. This a...
A new Gallup survey finds Americans would rather live near a nuclear plant than a data center, highlighting rising lo...
Get an in-depth look at Paysafe (PSFE) 2026 earnings outlook. We break down Q1 results, revenue streams, margin trend...
Oklo stock climbing higher this week is driven by regulatory progress on its Aurora reactor and broader interest in a...
Bitcoin climbs toward a potential retest of $90,000, but a stubborn sell wall tied to trapped traders keeps gains lim...
Savers are flocking to online banks as market rates push up high yield savings account APYs. This guide explains how ...
A director’s stock sale can spark worry, but not every insider move is a warning. This guide shows how to assess trad...
Wendy’s shares jumped about 27% on the CFO announcement, fueled by a Reddit-driven Save Wendy’s meme rally. Quarterly...
A contractor seeks over $1 million in damages from Kanye West over renovations at his Malibu beach house. The civil t...
Bitcoin briefly topped $80,000 again as traders weigh whether the move signals real demand or a looming reversal. Ana...
Microsoft’sAI push fuels cloud and enterprise gains even as capital outlays rise and OpenAI losses widen. Analysts ma...